Table 1 Backgrounds of patients.
n = 153 (%) | |
|---|---|
Age: years, mean ± SD | 73 ± 9.2 |
Male: n (%) | 114 (75) |
Etiology: virus/alcohol/NASH/others | 100/19/33/1 (65/12/22/1) |
Body mass index, mean ± SD | 22 ± 3.4 |
Complicated with diabetes: n (%) | 44 (29) |
Maximum size of HCC nodule in the liver: mm, median (range in IQR) | 35 (18–68) |
Number of HCC nodules: 1/2/3/4 or more, n (%) | 84/25/14/31 (54/16/9/21) |
Presence of ascites: n (%) | 30 (20) |
Presence of hepatic encephalopathy: n (%) | 8 (5.2) |
Child-Pugh grade: A/B/C: n (%) | 93/46/14 (62/29/9) |
HCC stage: 1/2/3/4, n (%) | 26/62/32/33 (17/41/21/21) |
JIS score: 0/1/2/3/4/5, n (%) | 15/56/34/25/17/6 (10/37/22/16/11/5) |
Albumin: g/dl, mean ± SD | 3.6 ± 0.62 |
Total bilirubin: g/dl, mean ± SD | 1.7 ± 2.8 |
γ-GTP: U/l, mean ± SD | 142 ± 194 |
Prothrombin time: %, mean ± SD | 82 ± 20 |
AFP: ng/ml, median (range in IQR) | 33 (6.2–177) |
AFP L3 index: %, median (range in IQR) | 7.8 (2.1–44) |
PIVKA-α: mAU/ml, median (range in IQR) | 117 (23–3675) |
Presence of presarcopenia: n (%) | 43 (28) |
